Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:21811105n
Noun Named Entity
IT
No term available
EN
Cambiogenplasmid, marketed as Neovasculgen, is a gene therapy drug for treatment of peripheral artery disease, including critical limb ischemia; it delivers the gene encoding for vascular endothelial growth factor. Wikipedia
Relations
Sources
IS A
terapia genica

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License